Trial Profile

Hemoglobin maintenance in pediatric ESRD patients by ferric pyrophosphate citrate (FPC)

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 07 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ferric pyrophosphate (Primary)
Indications Iron deficiency anaemia
Focus Adverse reactions; Registrational
Sponsors Rockwell Medical Technologies

Most Recent Events

03 May 2021 This trial has been discontinued in Poland, according to European Clinical Trials Database record.
17 Feb 2021 This trial has been completed in Germany.
03 Feb 2021 Planned End Date changed from 1 Sep 2022 to 1 Nov 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com